Evidence map›Paper›PMID 33649810›Full record

ArticleOncology reports2021

Dong Hyuck Bae, Hee-Jin Kim, Byoung-Ha Yoon, Jong-Lyul Park, Mirang Kim, Seon-Kyu Kim, Seon-Young Kim, Sang-Il Lee, Kyu-Sang Song, Yong Sung Kim

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. NSUN7-mediated mJournal of translational medicine · 2025
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Dong Hyuck BaeGenome Editing Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Republic of Korea.
Hee-Jin KimGenome Editing Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Republic of Korea.
Byoung-Ha YoonPersonalized Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Republic of Korea.
Jong-Lyul ParkGenome Editing Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Republic of Korea.
Mirang KimDepartment of Functional Genomics, Korea University of Science and Technology, Daejeon 34113, Republic of Korea.
Seon-Kyu KimPersonalized Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Republic of Korea.
Seon-Young KimDepartment of Functional Genomics, Korea University of Science and Technology, Daejeon 34113, Republic of Korea.
Sang-Il LeeDepartment of Surgery, College of Medicine, Chungnam National University, Daejeon 35015, Republic of Korea.
Kyu-Sang SongDepartment of Pathology, College of Medicine, Chungnam National University, Daejeon 35015, Republic of Korea.
Yong Sung KimGenome Editing Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Republic of Korea.
Korea Research Institute of Bioscience and Biotechnology · KRChungnam National University · KRKorea University of Science and Technology · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pathological changes in the epigenetic landscape of chromatin are hallmarks of cancer. Our previous study showed that global methylation of promoters may increase or decrease during the transition from gastric mucosa to intestinal metaplasia (IM) to gastric cancer (GC). Here, CpG hypomethylation of the serine/threonine kinase

Indexed as

Chromatin Assembly and DisassemblyGene Expression Regulation, NeoplasticAdultAgedAged, 80 and overAnimalsBiomarkers, TumorCarcinogenesisCpG IslandsDNA MethylationFemaleGastric MucosaGene Knockdown TechniquesHumansMaleMiceBiomarkers, TumorProtein Serine-Threonine KinasesSTK31 protein, humanchromatin remodelingDNA hypomethylationgastric cancerprognosisserine/threonine kinase 31

Identifiers

PMID33649810
PMCPMC7934220
OpenAlexW3130114940

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.